Suppr超能文献

全身免疫炎症指数作为动脉粥样硬化负担和急性冠状动脉综合征高危患者的决定因素。

Systemic Immune-Inflammatory Index as a Determinant of Atherosclerotic Burden and High-Risk Patients with Acute Coronary Syndromes.

机构信息

Namik Kemal University,Faculty of Medicine, Department of Cardiology, Tekirdag - Turquia.

Namik Kemal University,Faculty of Medicine, Biochemistry Department, Tekirdag - Turquia.

出版信息

Arq Bras Cardiol. 2022 Sep;119(3):382-390. doi: 10.36660/abc.20210416.

Abstract

BACKGROUND

Systemic immune-inflammatory index (SII), which is derived from neutrophil, platelet and lymphocyte counts, represents the homeostatic balance among inflammatory, immune and thrombotic status. The systemic immune-inflammatory index is superior to indices such as neutrophil-lymphocyte ratio in predicting prognosis in various malignancies, while it is shown to predict future cardiac events better than traditional risk factors after coronary intervention.

OBJECTIVES

Herein, we aimed to evaluate the relationship of the systemic immune-inflammatory index with atherosclerotic burden and in-hospital complications in acute coronary syndrome patients.

METHODS

The clinical outcomes, such as extent of myocardial damage, atherosclerotic burden, bleeding, acute kidney injury, duration of hospital stay and in-hospital mortality, were evaluated in a retrospective cohort of 309 consecutive acute coronary syndrome patients. The systemic immune-inflammatory index was calculated as (Platelet X Neutrophil)/Lymphocyte count on admission. Study population was categorized into tertiles with regard to systemic immune-inflammatory index. A p value of <0.05 was considered statistically significant.

RESULTS

The highest systemic immune-inflammatory index values were within ST elevation myocardial infarction patients (641.4 in unstable angina pectoris, 843.0 in non-ST elevation myocardial infarction patients and 996.0 in ST elevation myocardial infarction patients; p=0.004). Maximal troponin concentration (0.94 vs. 1.26 vs. 3; p<0.001), number of diseased vessels (1 vs. 2 vs. 2; p<0.001), the SYNTAX (synergy between percutaneous coronary intervention with taxus and coronary artery bypass grafting) score (9 vs. 14 vs. 17.5; p<0.001) and duration of hospital stay (2 vs. 2 vs. 3; p<0.001) also increased with increasing SIItertile(tertile1 vs. tertile 2 vs. tertile 3). Systemic immune-inflammatory index was an independent predictor of SYNTAX score (ß: 0.232 [0.001 to 0.003]; p<0.001), extent of myocardial damage (ß: 0.152 [0 to 0.001]; p=0.005) and duration of hospital stay (ß: 0.168 [0.0 to 0.001]; p=0.003).

CONCLUSIONS

This study has demonstrated that the systemic immune-inflammatory index, a simple hematological index, is a marker of atherosclerotic burden and longer hospital stay on well-known risk factors in high risk acute coronary syndrome patients.

摘要

背景

系统免疫炎症指数(SII)由中性粒细胞、血小板和淋巴细胞计数得出,代表炎症、免疫和血栓形成状态之间的平衡。与中性粒细胞-淋巴细胞比值等指数相比,SII 能更好地预测各种恶性肿瘤的预后,而与传统危险因素相比,SII 能更好地预测经皮冠状动脉介入治疗后的未来心脏事件。

目的

本研究旨在评估系统免疫炎症指数与急性冠状动脉综合征患者动脉粥样硬化负担和住院期间并发症的关系。

方法

回顾性分析了 309 例连续急性冠状动脉综合征患者的临床结局,如心肌损伤程度、动脉粥样硬化负担、出血、急性肾损伤、住院时间和住院期间死亡率。入院时计算系统免疫炎症指数为(血小板×中性粒细胞)/淋巴细胞计数。根据系统免疫炎症指数将研究人群分为三分位。p 值<0.05 被认为具有统计学意义。

结果

ST 段抬高型心肌梗死患者的系统免疫炎症指数最高(不稳定型心绞痛患者为 641.4,非 ST 段抬高型心肌梗死患者为 843.0,ST 段抬高型心肌梗死患者为 996.0;p=0.004)。最大肌钙蛋白浓度(0.94 vs. 1.26 vs. 3;p<0.001)、病变血管数(1 vs. 2 vs. 2;p<0.001)、SYNTAX 评分(经皮冠状动脉介入治疗与紫杉醇联合冠状动脉旁路移植术之间的协同作用)(9 vs. 14 vs. 17.5;p<0.001)和住院时间(2 vs. 2 vs. 3;p<0.001)也随 SII 三分位的升高而增加(三分位 1 vs. 三分位 2 vs. 三分位 3)。系统免疫炎症指数是 SYNTAX 评分的独立预测因子(β:0.232 [0.001 至 0.003];p<0.001)、心肌损伤程度(β:0.152 [0 至 0.001];p=0.005)和住院时间(β:0.168 [0 至 0.001];p=0.003)。

结论

本研究表明,系统免疫炎症指数作为一种简单的血液学指标,是高危急性冠状动脉综合征患者已知危险因素下动脉粥样硬化负担和住院时间延长的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3f/9438541/ba016f91b358/0066-782X-abc-119-03-0382-gf01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验